JPI InvestFrançais
JPI AI Analyst AI assistant · JPI Invest
Answers based on the tool's data · not financial advice · full analysis (free)
All stocksHealth CareADMA › Financials

ADMA Biologics, Inc. (ADMA): financial analysis & fundamentals

Health Care · price $9.48 · market cap —
In short — ADMA Biologics, Inc. trades at —× earnings (P/E), —× expected earnings, for a PEG of — and a net margin of —. Revenue growth . Quick verdict: valuation to review.

📈 See the interactive version (live chart) →

🔗 Related pages on ADMA Biologics, Inc. — Are analysts right?  ·  If I had invested

Valuation & profitability

MetricValueWhat it means
P/E (price / earnings)The higher, the more growth the market expects.
Forward P/EOn next year's expected earnings. Lower than current P/E = rising earnings.
PEG (P/E ÷ growth)Below 1 = cheap given growth; above 2 = expensive.
Net marginShare of revenue that ends up as profit.
Revenue growthPace of revenue growth.
Price-to-bookPrice relative to book value.
Market capTotal market value of the company.
Dividend yieldNo dividend currently.

📊 Open the interactive ADMA Biologics, Inc. page (charts, live news) →

Frequently asked questions

Is ADMA Biologics, Inc. stock expensive?

ADMA Biologics, Inc. has a P/E of — (forward P/E —) and a PEG of —. A PEG below 1 is rather cheap given growth, above 2 is expensive. Verdict: valuation to review.

What is ADMA Biologics, Inc.'s net margin?

ADMA Biologics, Inc.'s net margin is about — — the share of revenue that ends up as net profit.

What is ADMA Biologics, Inc.'s revenue?

ADMA Biologics, Inc.'s income statement is detailed on this page.

What is ADMA Biologics, Inc.'s market cap?

ADMA Biologics, Inc. (ADMA) has a market cap of about —.

Does ADMA Biologics, Inc. pay a dividend?

No, ADMA Biologics, Inc. does not currently pay a dividend (it reinvests earnings).

What is JPI Invest?

JPI Invest aggregates analyst recommendations across the entire S&P 500 (plus the S&P MidCap 400), replays them against real prices and measures who predicts best — on results, not reputation. Instead of taking a price target at face value, you see each analyst's track record on each stock.

Explore JPI Invest for free → How it works: the method →

⚠️ Educational information, not investment advice. Data: Yahoo Finance, recomputed by JPI Invest. A stock can be « cheap » for a bad reason.